These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 2952710

  • 1. Antibodies to the common leukocyte antigen (T200) inhibit an early phase in the activation of resting human B cells.
    Mittler RS, Greenfield RS, Schacter BZ, Richard NF, Hoffmann MK.
    J Immunol; 1987 May 15; 138(10):3159-66. PubMed ID: 2952710
    [Abstract] [Full Text] [Related]

  • 2. Anti-CD45 inhibition of human B cell proliferation depends on the nature of activation signals and the state of B cell activation. A study with anti-IgM and anti-CDw40 antibodies.
    Gruber MF, Bjorndahl JM, Nakamura S, Fu SM.
    J Immunol; 1989 Jun 15; 142(12):4144-52. PubMed ID: 2470814
    [Abstract] [Full Text] [Related]

  • 3. Anti-HLA class I antibodies inhibit the T cell-independent proliferation of human B lymphocytes.
    Taylor DS, Nowell PC, Kornbluth J.
    J Immunol; 1987 Sep 15; 139(6):1792-6. PubMed ID: 3497978
    [Abstract] [Full Text] [Related]

  • 4. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
    Kabelitz D, Pfeffer K, von Steldern D, Bartmann P, Brudler O, Nerl C, Wagner H.
    J Immunol; 1985 Oct 15; 135(4):2876-81. PubMed ID: 2993419
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of natural killer-cell mediated cytolysis with monoclonal antibodies to restricted and non-restricted epitopes of the leucocyte common antigen.
    Starling GC, Davidson SE, McKenzie JL, Hart DN.
    Immunology; 1987 Jul 15; 61(3):351-6. PubMed ID: 2440797
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of anti-CD45 monoclonal antibody on human B cell proliferation: a monoclonal antibody recognizing a neuraminidase-sensitive epitope of the T200 molecule enhances anti-immunoglobulin-induced proliferation.
    Alsinet E, Inglés-Esteve J, Vilella R, Lozano F, Milá J, Rojo I, Martorell J, Vives J, Gayá A.
    Eur J Immunol; 1990 Dec 15; 20(12):2801-4. PubMed ID: 1702728
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of B cell proliferation with anti-CD19 monoclonal antibodies: anti-CD19 antibodies do not interfere with early signaling events triggered by anti-IgM or interleukin 4.
    Rigley KP, Callard RE.
    Eur J Immunol; 1991 Mar 15; 21(3):535-40. PubMed ID: 1707000
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.
    Lanier LL, Benike CJ, Phillips JH, Engleman EG.
    J Immunol; 1985 Feb 15; 134(2):794-801. PubMed ID: 3871216
    [Abstract] [Full Text] [Related]

  • 14. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40).
    Ledbetter JA, Shu G, Gallagher M, Clark EA.
    J Immunol; 1987 Feb 01; 138(3):788-94. PubMed ID: 3492534
    [Abstract] [Full Text] [Related]

  • 15. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
    Vujanovic NL, Herberman RB, Olszowy MW, Cramer DV, Salup RR, Reynolds CW, Hiserodt JC.
    Cancer Res; 1988 Feb 15; 48(4):884-90. PubMed ID: 3257412
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-4-mediated aggregation of anti-IgM-stimulated human B cells: inhibition of aggregation but enhancement of proliferation by antibodies to LFA-1.
    Björck P, Paulie S, Axelsson B.
    Immunology; 1992 Jan 15; 75(1):122-8. PubMed ID: 1537588
    [Abstract] [Full Text] [Related]

  • 17. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
    Tadmori W, Reed JC, Nowell PC, Kamoun M.
    J Immunol; 1985 Mar 15; 134(3):1709-16. PubMed ID: 2981919
    [Abstract] [Full Text] [Related]

  • 18. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines.
    Perussia B, Ramoni C, Anegon I, Cuturi MC, Faust J, Trinchieri G.
    Nat Immun Cell Growth Regul; 1987 Mar 15; 6(4):171-88. PubMed ID: 2960890
    [Abstract] [Full Text] [Related]

  • 19. A new epitope of the T200 molecule family defined by the 3A35 monoclonal antibody and expressed by macrophages and activated T lymphocytes.
    Le Corre R, Gerlier D, Martin A, Le Garrec Y, Corradin G, Bron C, Toujas L.
    Eur J Immunol; 1987 Mar 15; 17(3):327-33. PubMed ID: 2436920
    [Abstract] [Full Text] [Related]

  • 20. Novel antigenic determinants of the T200 glycoprotein expressed preferentially by activated cytotoxic T lymphocytes.
    Lefrançois L, Bevan MJ.
    J Immunol; 1985 Jul 15; 135(1):374-83. PubMed ID: 2582040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.